TP53 and neoplasm: It is possible that substantially increasing the sample size for these analyses would determine that a mixed-methods approach would pan out to be the most beneficial (IHC for RB1 and PTEN, and NGS for TP53); however, it is pertinent to note that IHC-based determination of TSP aberrancy did indeed correlate with tumor suppressor pathway LOF.